Chunxiao Liu

SOX9 is a dose-dependent metastatic fate determinant in melanoma

H. Lung, X. Guan, M. Cheung, 2019, Journal of Experimental & Clinical Cancer Research.

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.

Shizhong Xu, Zheng Liu, Tianxin Lin, 2020, The Journal of clinical investigation.

SOX9 is a dose-dependent metastatic fate determinant in melanoma

H. Lung, X. Guan, M. Cheung, 2019, Journal of experimental & clinical cancer research : CR.